Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized Trial of Intraoral, Extraoral, and Combined Intraoral/Extraoral Photobiomodulation for the Prevention of Oral Mucositis in Patients Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation

NCT07290413 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT07290413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07290413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized Trial of Intraoral, Extraoral, and Combined Intraoral/Extraoral Photobiomodulation for the Prevention of Oral Mucositis in Patients Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 1, 2025
Completion date
May 31, 2027
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral mucositis